Quarterly Result28 Apr 2026, 04:41 pm
Sanofi Consumer Healthcare India approves Q1 FY27 unaudited results
AI Summary
Sanofi Consumer Healthcare India Ltd's Board of Directors, at its meeting on April 28, 2026, approved the unaudited financial results for the quarter ended March 31, 2026. The company enclosed a copy of these results along with a Limited Review Report from its Statutory Auditors, Kalyaniwalla & Mistry LLP, as per SEBI Listing Regulations. The auditors confirmed that their review, conducted under SREs 2410, found no material misstatement in the financial statements, which were prepared in accordance with Ind AS 34. The results will be published in newspapers and made available on the company's website. The board meeting started at 1:00 p.m. and concluded at 3:40 p.m.
Key Highlights
- Board approved unaudited Q1 FY27 financial results.
- Results for quarter ended March 31, 2026, were considered.
- Statutory Auditors issued a Limited Review Report.
- Auditors found no material misstatement in the results.
- Results to be published and available on company website.
Price Impact
More from SANOFICONR